New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods

Home » New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods

View Larger Image

New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods

Download

File Type: pdf

Categories: Mental Health, PPG:TM Oxi

By Gateway Clinical|2022-10-06T08:43:31+00:00October 6, 2022|Comments Off

About the Author: Gateway Clinical

OUR COMPANY

A MEDICAL DEVICE PARTNER YOU CAN TRUST

We’re here with high quality medical products and the type of support you can only expect in the USA. Our pledge is to bring immediate value to your practice and help lower the cost of care.

GET STARTED

FAST DELIVERY
LOWEST PRICE GUARANTEE
PRACTICE INTEGRATION
ANALYSIS
FREE INSTALLATION
COMPREHENSIVE TRAINING
HARDWARE WARRANTY
SOFTWARE UPDATES
ONGOING SUPPORT
MARKETING CONSULTATION

(213) 537-6144

6600 Sunset Blvd, Los Angeles, California, 90028

New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods